Tweet
Smith & Nephew spray-on cell therapy flops in trial Reuters LONDON (Reuters) - A novel spray-on treatment consisting of living cells made by Smith & Nephew, which is designed to work with the body's own cells to help heal leg ulcers, has failed in a late-stage clinical trial. The product, known as HP802-247, was ... Smith & Nephew Says HP802-247 Fails To Meet Primary Endpoint - Quick FactsRTT News all 3 news articles » |
More...